Nicotine Increases Size and Severity of Experimental Choroidal Neovascularization

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 1, 2004, Pages 311-317

  Suñer, Ivan J ^a,b   Espinosa Heidmann, Diego G ^b   Marin Castano, Maria E ^b   Hernandez, Eleut P ^b   Pereira Simon, Simone ^b   Cousins, Scott W ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; HEXAMETHONIUM; NICOTINE; NICOTINIC RECEPTOR; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN;

ADOLESCENT; AGED; AGING; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL GROWTH; CELL LINE; CELL PROLIFERATION; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RETINA MACULA AGE RELATED DEGENERATION; SMOKING; SUBRETINAL NEOVASCULARIZATION; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

ADMINISTRATION, ORAL; ANIMALS; CELL DIVISION; CHOROID; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HEXAMETHONIUM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PLATELET-DERIVED GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0346727558     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0733     Document Type: Article

References (48)

1. Evans JR. Risk factors for age-related macular degeneration. Prog Retin Eye Res. 2001;20:227-253.
2. Green WR. Histopathology of age-related macular degeneration. Mol Vis. 1999;5:27.
3. Smith W, Mitchell P, Leeder SR. Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol. 1996;114:1518-1523.
4. Klein R, Klein BE, Linton KL, DeMets DL. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol. 1993;137:190-200.
5. Tamakoshi A, Yuzawa M, Matsui M, Uyama M, Fujiwara NK, Ohno Y. Smoking and neovascular form of age related macular degeneration in late middle aged males: findings from a case-control study in Japan. Research Committee on Chorioretinal Degenerations. Br J Ophthalmol. 1997;81:901-904.
6. Seddon JM, Willett WC, Speizer FE, Hankinson SE. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA. 1996;276:1141-1146.
7. Delcourt C, Diaz JL, Ponton-Sanchez A, Papoz L. Smoking and age-related macular degeneration. The POLA Study (Pathologies Oculaires Liees a l'Age) Arch Ophthalmol. 1998;116:1031-1035.
8. Christen WG, Glynn RJ, Manson JE, Ajani UA, Buring JE. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA. 1996;276:1147-1151.
9. Smith CJ, Hansch C. The relative toxicity of compounds in mainstream cigarette smoke condensate. Food Chem Toxicol. 2000;38:637-646.
10. Solberg Y, Rosner M, Belkin M. The association between cigarette smoking and ocular diseases. Surv Ophthalmol. 1998;42:535-547.
11. Villablanca AC. Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro. J Appl Physiol. 1998;84:2089-2098.
12. Heeschen C, Jang JJ, Weis M, et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med. 2001;7:833-839.
13. Jain RK. Clearing the smoke on nicotine and angiogenesis. Nat Med. 2001;7:775-777.
14. Espinosa-Heidmann DG, Suner I, Hernandez EP, Frazier WD, Csaky KG, Cousins SW. Age as an independent risk factor for severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2002;43:1567-1573.
15. Marin-Castano ME, Elliot SJ, Potier M, et al. Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2003;44:50-59.
16. Cucina A, Sapienza P, Corvino V, et al. Nicotine induces platelet-derived growth factor release and cytoskeletal alteration in aortic smooth muscle cells. Surgery. 2000;127:72-78.
17. Carty CS, Huribal M, Marsan BU, Ricotta JJ, Dryjski M. Nicotine and its metabolite cotinine are mitogenic for human vascular smooth muscle cells. J Vasc Surg. 1997;25:682-688.
18. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6:389-395.
19. Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol. 2001;21:1104-1117.
20. Tamaki M, McDonald W, Del Maestro RF. The importance of cell density in the interpretation of growth factor effects on collagenase IV activity release and extracellular matrix production from C6 astrocytoma cells. J Neurooncol. 1998;39:205-216.
21. Conklin BS, Zhao W, Zhong DS, Chen C. Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells. Am J Pathol. 2002;160:413-418.
22. Heeschen C, Weis M, Aicher A, Dimmeler S, Cooke JP. A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest. 2002;110:527-536.
23. Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res. 2003;22:1-29.
24. Cucina A, Borrelli V, Randone B, Coluccia P, Sapienza P, Cavallaro A. Vascular endothelial growth factor increases the migration and proliferation of smooth muscle cells through the mediation of growth factors released by endothelial cells. J Surg Res. 2003;109:16-23.
25. Leonard S, Bertrand D. Neuronal nicotinic receptors: from structure to function. Nicotine Tob Res. 2001;3:203-223.
26. Sharma G, Vijayaraghavan S. Nicotinic receptor signaling in non-excitable cells. J Neurobiol. 2002;53:524-534.
27. Macklin KD, Maus AD, Pereira EF, Albuquerque EX, Conti-Fine BM. Human vascular endothelial cells express functional nicotinic acetylcholine receptors. J Pharmacol Exp Ther. 1998;287:435-439.
28. Dewar BJ, Bradford BU, Thurman RG. Nicotine increases hepatic oxygen uptake in the isolated perfused rat liver by inhibiting glycolysis. J Pharmacol Exp Ther. 2002;301:930-937.
29. Benhammou K, Lee M, Strook M, et al. [H]Nicotine binding in peripheral blood cells of smokers is correlated with the number of cigarettes smoked per day. Neuropharmacology. 2000;39:2818-2829.
30. Maus AD, Pereira EF, Karachunski PI, et al. Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. Mol Pharmacol. 1998;54:779-788.
31. Zia S, Ndoye A, Lee TX, Webber RJ, Grando SA. Receptor-mediated inhibition of keratinocyte migration by nicotine involves modulations of calcium influx and intracellular concentration. J Pharmacol Exp Ther. 2000;293:973-981.
32. Hosli E, Jurasin K, Ruhl W, Luthy R, Hosli L. Colocalization of androgen, estrogen and cholinergic receptors on cultured astrocytes of rat central nervous system. Int J Dev Neurosci. 2001;19:11-19.
33. Smit AB, Syed NI, Schaap D, et al. A glia-derived acetylcholine-binding protein that modulates synaptic transmission. Nature. 2001;411:261-268.
34. Wessler I, Kirkpatrick CJ, Racke K. Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol Ther. 1998;77:59-79.
35. Conti-Fine BM, Navaneetham D, Lei S, Maus AD. Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity? Eur J Pharmacol. 2000;393:279-294.
36. Frelin C, Ladoux A, D'angelo G. Vascular endothelial growth factors and angiogenesis. Ann Endocrinol (Paris). 2000;61:70-74.
37. Abedi H, Zachary I. Signalling mechanisms in the regulation of vascular cell migration. Cardiovasc Res. 1995;30:544-556.
38. Claesson-Welsh L. Signal transduction by the PDGF receptors. Prog Growth Factor Res. 1994;5:37-54.
39. Munaron L. Calcium signalling and control of cell proliferation by tyrosine kinase receptors (review). Int J Mol Med. 2002;10:671-676.
40. Srivastava AK, St Louis J. Smooth muscle contractility and protein tyrosine phosphorylation. Mol Cell Biochem. 1997;176:47-51.
41. Hoddelius P, Lirvall M, Wasteson A, Loitto V, Magnusson KE. Both intra- and extracellular Ca2+ participate in the regulation of the lateral diffusion of the PDGF-beta2 receptor. Biosci Rep. 2000;20:119-127.
42. Bilato C, Crow MT. Atherosclerosis and the vascular biology of aging. Aging (Milano). 1996;8:221-234.
43. Baylis C, Corman B. The aging kidney: insights from experimental studies. J Am Soc Nephrol. 1998;9:699-709.
44. Lundberg MS, Crow MT. Age-related changes in the signaling and function of vascular smooth muscle cells. Exp Gerontol. 1999;34:549-557.
45. Aliev G, Smith MA, Seyidov D, et al. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Brain Pathol. 2002;12:21-35.
46. Bundy RE, Marczin N, Birks EF, Chester AH, Yacoub MH. Transplant atherosclerosis: role of phenotypic modulation of vascular smooth muscle by nitric oxide. Gen Pharmacol. 2000;34:73-84.
47. Sarks JP, Sarks SH, Killingsworth MC. Morphology of early choroidal neovascularization in age-related macular degeneration: correlation with activity. Eye. 1997;11:515-522.
48. Espinosa-Heidmann DG, Caicedo A., Hernandez EP, Csaky KG, Cousins SW. Bone marrow-derived progenitor cells contribute to experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2003;44:4914-4919.